Interventional oncology and immunotherapy: current status and future perspectives
Interventional oncology has become an important part of multidisciplinary cancer treatment following the development of interventional radiology. Tumors can release antigens, activate immunity, and cause an abscopal effect after interventional therapy. However, the activated immune response is limit...
Saved in:
| Main Authors: | Ji Ma, Zhigang Wei, Xin Ye |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1541105/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization
by: Ken Zhao, et al.
Published: (2025-01-01) -
Case Report: Durable remission after abscopal effect following transcatheter hepatic arterial embolization in a patient with mucosal melanoma refractory to immunotherapy
by: Lynsey M. Claus, et al.
Published: (2025-04-01) -
Optical imaging guidance in oncologic surgery and interventional oncology
by: Yiming Liu, et al.
Published: (2025-02-01) -
Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness
by: Tao Huang, et al.
Published: (2022-12-01) -
Clinical outcomes after emergency transarterial renal embolization: a retrospective study
by: Rémi Grange, et al.
Published: (2024-12-01)